Incidence of secondary primary cancers in metastatic #Melanoma, #LungCancer, #HepatocellularCarcinoma, and #UrothelialCarcinoma did not differ between pre- and post–immune checkpoint inhibitor approval periods. bit.ly/46ySDYm